NASDAQ · PPH
VanEck Pharmaceutical ETF
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
Loading market information…
NASDAQ · FEPI · USD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
REX FANG & Innovation Equity Premium Income ETF’s quoted price sits in the lower half of its reported 52-week range, 20.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
REX FANG & Innovation Equity Premium Income ETF’s forward annual dividend is $10.21 per share, paid weekly. The forward yield is 26.47% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow REX FANG & Innovation Equity Premium Income ETF’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The REX FANG & Innovation Equity Premium Income ETF, or FEPI, utilizes a covered call strategy designed to achieve two main goals: generating income and providing exposure to potential growth within the technology sector. The fund accomplishes this by maintaining positions in the stocks comprising its benchmark, the Solactive FANG Innovation Index, and simultaneously selling call options on these shares that are slightly out-of-the-money. This approach leverages the significant volatility often found in major technology companies, thereby earning premium income from the options. However, it also means that some of the potential upside from stock appreciation is capped. An additional benefit is a modest safeguard against drops in stock prices. It's important to recognize, though, that this protective buffer is confined to the option premiums received and may not completely negate substantial declines in the underlying securities. The fund's benchmark is an equally weighted index made up of fifteen U.S. technology firms. Eight of these are considered foundational holdings: Apple, Alphabet, Amazon, Meta, Microsoft, Netflix, Nvidia, and Tesla. The other seven companies are chosen quarterly from a diverse range of Factset technology-related industries, based on their trading volumes.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 10:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$89.89-$2.67 (-2.88%)
Fidelity Momentum Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 9.08% below the high.
$34.51-$0.26 (-0.75%)
Innovator U.S. Equity 10 Buffer ETF - Quarterly’s quoted price sits in the upper half of its reported 52-week range, 0.98% below the high.
$43.75-$0.47 (-1.06%)
Natixis Loomis Sayles Focused Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 5.63% below the high.
$35.85-$0.80 (-2.18%)
FT Vest Nasdaq-100 Buffer ETF - December’s quoted price sits in the upper half of its reported 52-week range, 3.78% below the high.
$66.71-$0.57 (-0.84%)
Longview Advantage ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$29.90-$0.36 (-1.18%)
SMI 3Fourteen REAL Asset Allocation ETF’s quoted price sits in the upper half of its reported 52-week range, 2.72% below the high.
$46.24-$0.03 (-0.06%)
Pacer Aristotle Pacific Floating Rate High Income ETF’s quoted price sits in the lower half of its reported 52-week range, 3.02% below the high.
